TOP TIERMARKET NEWSWIRE
SEC Form 4 history

XERIS BIOPHARMA HLDG (XERS) insider trades

XERIS BIOPHARMA HLDG (XERS) insider trading activity (SEC Form 4). Over the trailing 90 days, XERS insiders filed 0 purchases totalling $0 and 10 sales totalling $2.0M — net SELLING of $2.0M. Most recent filing: Aug 4, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
10
$2.0M
Net (90d)
-$2.0M
net selling
Most recent
Aug 4, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 4, 2026McCulloch KevinSee RemarksS Sale—$8.02$120Kfiling
Aug 4, 2026Hecht BethSee RemarksS Sale—$8.01$134Kfiling
Jul 7, 2026Pieper StevenSee RemarksS Sale—$8.52$383Kfiling
Jul 2, 2026McCulloch KevinSee RemarksS Sale—$8.03$723Kfiling
Jul 2, 2026Hecht BethSee RemarksS Sale—$8.03$134Kfiling
Jun 5, 2026Johnson JohnDirS SaleOE—$6.09$91Kfiling
Jun 5, 2026Bormann-Kennedy Barbara-Jean AnneDirS SaleOE—$6.09$98Kfiling
Jun 5, 2026Halkuff DawnDirS SaleOE—$6.09$122Kfiling
Jun 5, 2026Persky MarlaDirS SaleOE—$5.90$91Kfiling
Jun 2, 2026Hecht BethSee RemarksS Sale—$6.06$101Kfiling